Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 54 of 3119 for:    Area Under Curve AND Healthy

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (TROIKA-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03776240
Recruitment Status : Recruiting
First Posted : December 14, 2018
Last Update Posted : May 6, 2019
Sponsor:
Information provided by (Responsible Party):
Prestige Biopharma Pte Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : July 2019